A Clinical Study of Islatravir and Ulonivirine for People With HIV-1 Who Have Not Been Treated Before (MK-8591B-062)

Clinical trial NCT07266831 · RECRUITING

Trial details

NCT number: NCT07266831
Sponsor: Merck Sharp & Dohme LLC
Status: RECRUITING
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Human Immunodeficiency Virus Type 1 (HIV-1) Infection

Start date: 2025-12-18
Primary completion: 2029-03-21
Enrollment: 570

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.